0 Комментарии
0 Поделились
542 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Can COPD Be Prevented? Steps to Protect Your Lungs from Early DamageIntroduction: A Hidden Burden and the Prevention Hope Did you know that chronic obstructive pulmonary disease (COPD) was responsible for about 3.5 million deaths worldwide in 2021, making it one of the top causes of mortality globally? In many countries, tobacco smoking accounts for over 75 percent of COPD cases, while in lower-income regions, indoor air pollution is also a major...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
COPD Market Overview, Treatment Trends & Growth Forecast"Executive Summary Chronic Obstructive Pulmonary Disease Market : CAGR Value Data Bridge Market Research analyzes that the global chronic obstructive pulmonary disease market which was USD 19.8 billion in 2022, would rocket up to USD 30.4 billion by 2030, and is expected to undergo a CAGR of 4.4% during the forecast period 2023 to 2030. The transparent, trustworthy and...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Smartphone-Linked Inhaler Drug Market Revolutionizes Asthma and COPD Management"Competitive Analysis of Executive Summary Smartphone-Linked Inhaler Drug Market Size and Share CAGR Value The global smartphone-linked inhaler drug market size was valued at USD 324.43 million in 2024 and is expected to reach USD 815.40 million by 2032, at a CAGR of 12.21% during the forecast period Global Smartphone-Linked Inhaler Drug Market report...0 Комментарии 0 Поделились 773 Просмотры 0 предпросмотр
-
Combihale FF 250 – Breathe Better with CFC Free InhalerCombihale FF CFC Free 250 Inhaler is formulated for effective control of asthma and chronic obstructive pulmonary disease (COPD). Its dual-action formula combines Fluticasone, a corticosteroid that reduces inflammation, and Formoterol, a bronchodilator that relaxes airway muscles for smoother airflow. This inhaler offers safe, sustainable relief with a CFC-free composition that protects the...0 Комментарии 0 Поделились 282 Просмотры 0 предпросмотр
-
Digihaler SF 250 – Trusted Therapy for Better BreathingDigihaler SF 250 is a widely recommended inhaler for patients who need consistent relief from persistent asthma and COPD. Its dual-action formulation supports easy breathing by relaxing airway muscles and reducing swelling inside the lungs. Designed for long-term management, Digihaler SF 250 helps control symptoms such as wheezing, tight chest, and shortness of breath, and reduces the risk of...0 Комментарии 0 Поделились 262 Просмотры 0 предпросмотр
-
Pulmonary Function Testing Market Overview, Growth Analysis, Trends and Forecast By 2032"Detailed Analysis of Executive Summary Pulmonary Function Testing Market Size and Share The global pulmonary function testing market size was valued at USD 3.88 billion in 2024 and is expected to reach USD 6.23 billion by 2032, at a CAGR of 6.10% during the forecast period When market research report is brilliant and precise, it proves to be a backbone for the...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр